Background {#Sec1}
==========

*Helicobacter pylori* infect over 50 % of the world's population, causing inflammatory gastritis, peptic ulcer disease, and gastric cancer \[[@CR1], [@CR2]\]. The molecular mechanisms and signaling pathways underlying the transition from *H. pylori* infection to gastric cancer remain unclear. *H. pylori* virulence factors including a cytotoxin-associated gene A (*cagA*), pathogenicity island (PAI), and vacuolating cytotoxin A (VacA) \[[@CR3]--[@CR6]\] have been associated with severe *H. pylori*-related disease. Specifically, *H. pylori* strains harboring an intact cag PAI, encoding components of a type IV secretion system (T4SS), are associated with a high risk of gastric cancer \[[@CR7], [@CR8]\]. The T4SS, which is comprised of multiple transporters including the CagE protein, is used to inject the immunodominant CagA protein into the gastric epithelial cells. Therefore, CagA secretion depends on the expression of functional genes that encode the T4SS including *cagE*. Upon translocation into the eukaryotic host cell, CagA is tyrosine phosphorylated by Src family of kinases of the host, which lead to rearrangement of the host cell cytoskeleton termed the "hummingbird phenotype" and subsequent induction of cell scattering \[[@CR9], [@CR10]\]. This phenomena is widely considered to be important in neoplastic transformation \[[@CR11], [@CR12]\]. Phosphorylated CagA interacts with several major host cell signal-transduction pathways \[[@CR13], [@CR14]\] affecting cell morphology changes such as cell elongation and motility (see review \[[@CR15]\]).

Several intracellular signaling pathways are activated upon *H. pylori* infection of host gastric epithelial cells \[[@CR9], [@CR10], [@CR13]--[@CR19]\]. Specifically, CagA interaction with SHP2 phosphatase and the Src family of kinases of the host cell are examples of how *H. pylori* is thought to hijack intracellular signaling pathways and potentially contribute to cancer development \[[@CR20]\]. However, it is unlikely that signaling through these two pathways are exclusively associated with *H. pylori* pathogenesis. Therefore, we wanted to characterize gastric epithelial cellular signaling responses following *H. pylori* infection, with a focus on pro-survival signals from PDK-1, which has not been investigated in relation to *H. pylori* infection.

The best characterized cell survival signaling pathway is the PI 3-kinase/PDK-1/Akt pathway. Upon binding to activated tyrosine kinase receptors, phosphatidylinositol 3-OH-kinase (PI 3-K) phosphorylates inositol phospholipids at the D-3 position of the inositol ring to generate phosphatidylinositol 3,4-bisphosphate (PI-3,4-P2) and phosphatidylinositol 3,4,5-trisphosphate (PI-3,4,5-P3). These lipids serve as membrane docking sites for many pleckstrin homology (PH) domain-containing proteins, including PDK-1 and Akt. Phosphorylation of Akt by PDK-1 activates the enzyme which phosphorylates a number of pro-survival proteins \[[@CR21], [@CR22]\].

PDK-1 is a multi-domain enzyme that contains an amino terminal kinase domain and a carboxy terminal PH domain separated by a small linker region. The enzyme is constitutively autophosphorylated at position Ser 241 within the activation loop (kinase subdomain VIII) \[[@CR23]\]. The primary function of PDK-1 appears to be that of a master regulatory protein kinase. PDK-1 phosphorylates the activation loop of AGC serine/threonine kinase family members including protein kinase A (cAMP-dependent protein kinase), protein kinase B (Akt), protein kinase C (PKC) isoforms, p70^S6^ kinase, and serum- and glucocorticoid-inducible kinase resulting in catalytic competence \[[@CR24]--[@CR31]\]. Phosphorylation of the activation loop in AGC protein kinases is thought to regulate access of substrates to the catalytic pocket. Phosphorylation of the specific activation loop, serine/threonine is required for complete activation of these kinases and initiates specific signaling pathways that ultimately lead to many of the cellular responses associated with PI 3-K \[[@CR32]\]. Each kinase phosphorylated by PDK-1 therefore controls specific signaling pathways in time and space, placing PDK-1 at the apex of complex networks of intracellular signaling. The purpose of our study was therefore to determine whether PDK-1 plays a role in an *in vitro H. pylori* infection model with a human gastric epithelium cell line.

Methods {#Sec2}
=======

Cell culture {#Sec3}
------------

The human gastric adenocarcinoma cell line, AGS (ATCC CRL 1739) was grown in RPMI 1640 medium (Cellgro, Herndon, VA) supplemented with 10 % heat inactivated fetal calf serum (FCS, HyClone Laboratories, Logan, UT) and 100 U/ml penicillin/ 100 μg/ml streptomycin (Pen/Strep; Cellgro) and incubated at 37 °C with 5 % CO~2~. Twenty four hours prior to infection with *H. pylori*, cells were washed and cultured in antibiotic-free medium at a concentration of 5 × 10^5^ cells/ml. AGS cells were infected with various strains of *H. pylori* (SS1, 26695, 60190, G27, and SD4; each at a multiplicity of infection, MOI of 100) for 24 h. Additionally, AGS cells were infected with heat-killed *H. pylori* (60190) at a concentration equivalent to an MOI of 100. Cells were also treated with the Src inhibitor, PP2 (10 μM) for 24 h.

*H. pylori* strains {#Sec4}
-------------------

*H. pylori* strains used in this study including their virulence traits are listed in Table [1](#Tab1){ref-type="table"}. *H. pylori* were routinely maintained on solid medium, Columbia agar (Becton Dickinson, MD) supplemented with 5 % laked blood and grown at 37 °C under microaerophilic conditions (5 % O~2~, 10 % CO~2~, 85 % N~2~) as previously described \[[@CR33]\]. Bacteria used to infect gastric epithelial cells were subcultured into liquid medium, brain heart infusion broth (BHI, Becton Dickinson) supplemented with 5 % FCS and cultured for 24 h on a reciprocal shaker at 37 °C under microaerophilic conditions. Before infections, spiral bacteria were enumerated using a Petroff-Hausser chamber and added to gastric cells at an MOI of 100. Bacteria used for infections were in the logarithmic phase of growth. To heat-inactivate *H. pylori*, bacteria were heated at 100 °C for 10 min.Table 1*H. pylori* strains used in this studyNameVirulence traitsReference60190*vacA* (s1a/m1) and *cagA* positive\[[@CR47]\]26695*vacA* (s1b/m1) and *cagA* positive\[[@CR63], [@CR64]\]^a^G27*vacA* (s1b/m1) and *cagA* positive\[[@CR65], [@CR66]\]^a^SS1*vacA* (s2/m2) and *cagA* positive\[[@CR63], [@CR67]\]SD4*vacA* and *cagA* positive\[[@CR68]\]^a^Strain has been sequenced

SDS-PAGE and Western blotting {#Sec5}
-----------------------------

Both attached and detached gastric epithelial cells were harvested, washed in phosphate buffered saline (PBS) three times, lysed in buffer (20 mM HEPES, pH 7.5, 2 mM EDTA, 2 mM EGTA, 5 mM MgCl~2~, 300 μM phenylmethylsulfonyl fluoride, 1 mM vanadate, 40 μg/ml leupeptin, and 1 μM microcystin), sonicated, and resuspended in Laemmli sample buffer. The proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in 10 % gels and transferred to polyvinylidinedifluoride membranes (PVDF, Bio-Rad, Hercules, CA). Membranes were probed with the antibodies to phospho Ser 241 PDK-1, total PDK-1 protein, phospho Ser 473 Akt, total Akt protein, or heat shock protein 27 (Hsp27) which were all purchased from Cell Signaling Technologies (Danvers, MA). Proteins were detected using chemiluminescence and quantified with a CCD camera using an Alpha InnotechFluorQ bio-imaging system.

Generation of His-tagged PDK-1 {#Sec6}
------------------------------

His-tagged PDK-1 WT was expressed and purified from baculovirus-infected Sf21 cells. Sf21 cells were maintained in Hink's TNM-FH medium (Cellgro), supplemented with 10 % FCS and 1 % penicillin/streptomycin, and incubated for 4 days with a baculovirus encoding His-PDK-1. Purification was conducted using the IMAC purification kit on Profinia (Bio-Rad), and purity was assessed by Coomassie staining of SDS gels. Whole *H. pylori* lysates were directly incubated with purified recombinant His~6~-PDK-1 for up to 60 min.

Statistical analysis {#Sec7}
--------------------

Data are represented as mean ± standard deviation. Data from different groups were compared statistically using two-tailed Student's *t* test. *P* values of less than 0.05 were considered statistically significant.

Results {#Sec8}
=======

Effect of *H. pylori* infection on PDK-1-activity in gastric epithelial cells {#Sec9}
-----------------------------------------------------------------------------

Secretion of CagA by *H. pylori* into human cells through the T4SS, has previously been demonstrated to hijack intracellular signaling systems involving the tyrosine kinase Src, the tyrosine phosphatase SHP-2, and the adaptor protein Grb2 \[[@CR34], [@CR35]\]. We identified Src and Grb2 as PDK-1binding proteins through a proteomic screen (King, unpublished results), suggesting that PDK-1 activity may also be regulated in response to *H. pylori* infection. In initial studies, we wanted to determine whether incubation of *H. pylori* with a gastric epithelial cell line, AGS could directly modulate signaling through PI 3-kinase. Cells were infected for 24 h with five different *H. pylori* strains: SS1, 26695, 60190, G27, and SD4. Incubation of cells with *H. pylori* resulted in dephosphorylation of endogenous PDK-1 at Ser 241 (Fig. [1a](#Fig1){ref-type="fig"}, upper panel). The extent of dephosphorylation of PDK-1 was dependent upon the strain of *H. pylori* used, with the 60190 strain being the most effective. It was possible that incubation of *H. pylori* with AGS cells simply activated destruction of the PDK-1 protein, which would explain the loss of phosphorylation at serine 241. To test this, we stripped the blot and re-probed for total PDK-1 protein (Fig. [1a](#Fig1){ref-type="fig"}, lower panel). Although we did see some proteolytic clipping of the PDK-1 protein, it largely remained intact, suggesting that *H. pylori* infection of AGS cells resulted in dephosphorylation of PDK-1. Next, we measured the activity of endogenous PDK-1 in AGS cells after incubation with the most effective *H. pylori* strain, 60190 for 24 h. There was an 85 % decrease in Ser 241 phosphorylation but no significant loss of PDK-1 protein (Fig. [1b](#Fig1){ref-type="fig"}).Fig. 1Incubation of *H. pylori* with AGS cells resulted in dephosphorylation of PDK-1 at Ser 241. **a** After infection with *H. pylori* strains SS1, 26695, 60190, G27, or SD4, total AGS protein was separated by SDS-PAGE followed by Western blot to detect phopho Ser 241 PDK-1 (upper panel) and total PDK-1 protein (lower panel). **b** *H. pylori*, strain 60190 incubated with AGS cells for 24 h and PDK-1 phosphorylation at Ser 241 and total protein levels were quantified. Both phospho Ser 241 and total protein levels were normalized to the housekeeping protein Hsp27. The amount of phosphorylation or total PDK-1 protein is expressed as a ratio of control protein, i.e. (phospho protein/Hsp27)/(total protein/Hsp27). Data are representative of at least 5 different experiments and presented as a percent of control and indicate the relative amount of phosphorylation or protein remaining in the system

Infection of AGS cells with *H. pylori* results in altered phosphorylation of Akt {#Sec10}
---------------------------------------------------------------------------------

Phosphorylation of PDK-1 at Ser 241 has been reported to be constitutive and necessary for phosphorylation of downstream substrates \[[@CR36]\]. Therefore, we wanted to determine whether incubation of AGS with the *H. pylori* strain 60190, which robustly desphosphorylated Ser 241 had an effect on Akt. Endogenous Akt activity was measured in AGS cells after incubation with *H. pylori* 60190 for 24 h. Incubation of cells with *H. pylori* resulted incomplete dephosphorylation of endogenous Akt at Ser 473 (Fig. [2a](#Fig2){ref-type="fig"}, upper panel). Interestingly, the Akt protein was substantially and specifically degraded upon treatment with *H. pylori* (Fig. [2a](#Fig2){ref-type="fig"}, middle panel), but a control protein, Hsp27 was not affected. An 80 % decrease in Ser 473 phosphorylation and 78 % decrease in Akt protein were observed in cells incubated with *H. pylori* 60190 (Fig. [2b](#Fig2){ref-type="fig"}).Fig. 2*H. pylori* associated dephosphorylation of PDK-1 alters the phosphorylation stability of Akt. **a** After infection with *H. pylori* strains SS1, 26695, 60190, G27, or SD4, total AGS protein was separated by SDS-PAGE followed by Western blot to detect phopho Ser 473 Akt (upper panel), total Akt (middle panel), or Hsp27 (bottom panel). **b** *H. pylori*, strain 60190 was incubated with AGS cells for 24 h and Akt phosphorylation at Ser 473 and total protein levels were quantified. Both phospho Ser 473 and total protein levels were normalized to the housekeeping protein Hsp27 and expressed as a ratio of control protein, i.e. (phospho protein/Hsp27)/(total protein/Hsp27). Data are representative of at least 3 different experiments and presented as a percent of control and indicate the relative amount of phosphorylation or protein remaining in the system

Mechanism of *H. pylori* dephosphorylation of PDK-1 {#Sec11}
---------------------------------------------------

To further explore the effect of *H. pylori* on PDK-1 activity, *H. pylori* strain 60190 was used. Endogenous PDK-1 Ser 241 was robustly dephosphorylated upon incubation of AGS cells with *H. pylori* 60190, but not in cells incubated with heat-inactivated *H. pylori* 60190, indicating that the *H. pylori* effect on PDK-1 was proteinaceous (Fig. [3a](#Fig3){ref-type="fig"}). To determine whether *H. pylori* directly secreted a protein phosphatase that dephosphorylates PDK-1, purified recombinant His~6~-PDK-1 generated in baculovirus and constitutively phosphorylated at Ser 241, was incubated with whole *H. pylori* lysate for up to 1 h (Fig. [3b](#Fig3){ref-type="fig"}). At various times, His~6~-PDK-1 was removed from the incubation mixture and phosphorylation at Ser 241 was verified by Western blotting. No significant decrease in phosphorylation over the 1 h time course was observed, suggesting that PDK-1 is not the direct target of a secreted *H. pylori* protein.Fig. 3PDK-1 dephosphorylation in the presence of *H. pylori* is indirect. **a** Representative Western blot of phospho Ser 241 PDK-1 and total PDK-1 protein following incubation of AGS cells with live (lane 2) or heat-killed *H. pylori* (lane 3). Total PDK-1 protein ran as two distinct species, one at the expected molecular weight (arrow) and at a faster migrating band (\*) that was likely proteolytically cleaved. **b** Incubation of whole *H. pylori* lysates with purified recombinant His~6~-PDK-1. **c** Incubation of AGS cells with *H. pylori* in the absence or presence of Src inhibitor, PP2

To determine whether signal transduction through Src, a previously known *H. pylori* target in mammalian cells, was indirectly responsible for the dephosphorylation of PDK-1, AGS cells were next incubated with *H. pylori*, SD4. We switched to SD4 because this strain previously yielded a strong hummingbird effect (data not shown). Therefore, this made it an efficient system to study the effects of Src. AGS cells were incubated with *H. pylori* SD4 for 24 h in the absence or presence of a Src inhibitor, PP2 (Fig. [3c](#Fig3){ref-type="fig"}). As expected control cells incubated without *H. pylori*, had robust Ser 241 phosphorylation, while cells incubated with *H. pylori* had decreased Ser 241 phosphorylation. Treatment with PP2 did not abrogate PDK-1 dephosphorylation. As a control that PP2 was working, the AGS cells did not display the typical 'hummingbird' phenotype (data not shown), which is known to be Src dependent \[[@CR10], [@CR34], [@CR37]\]. Taken together, these results suggest that the effect of *H. pylori* on PDK-1 Ser 241 phosphorylation is not a Src-mediated event.

The role of *H. pylori* type IV secretion system in PDK-1dephosphorylation {#Sec12}
--------------------------------------------------------------------------

We next wanted to determine whether disruption of the T4SS machinery could alter the ability of *H. pylori* to modulate PDK-1 phosphorylation. Minimal PDK-1 dephosphorylation observed in the SS1 strain (Fig. [1a](#Fig1){ref-type="fig"}), which is reported to have a non-functional T4SS \[[@CR38]\] suggests that a defect in the ability of *H. pylori* to deliver CagA into the target cell might be involved in this effect. To test this, we used CagE deficient *H. pylori* (SD4 *cagE*-), which are unable to deliver CagA protein into gastric epithelial cells \[[@CR39], [@CR40]\]. Triplicate samples of AGS cells were infected with either wild type SD4 *H. pylori* strain or SD4 *cagE*- for 24 h and the phosphorylation state of PDK-1 was monitored by Western blot (Fig. [4a](#Fig4){ref-type="fig"} top panel). Almost complete dephosphorylation (96 %) of endogenous PDK-1 at Ser 241 was observed in cells infected with the wild type SD4 *H. pylori* (Fig. [4b](#Fig4){ref-type="fig"}). In cells infected with SD4 *cagE*-, residual PDK-1 phosphorylation was detected, but was also greatly reduced (\>80 %) suggesting that the T4SS plays a minor role in this process (Fig. [4a](#Fig4){ref-type="fig"}, top panel and Fig. [4b](#Fig4){ref-type="fig"}). Reprobing with PDK-1 again showed that the protein remained largely intact, however, partial clipping of PDK-1 protein was observed in the presence of wild-type and *cagE* deficient *H. pylori* (Fig. [4a](#Fig4){ref-type="fig"}, middle panel). A Western blot of Hsp27 is shown in the bottom panel as a loading control (Fig. [4a](#Fig4){ref-type="fig"}, bottom panel). Because only partial recovery of PDK-1 phosphorylation was observed in the presence of the *cagE*- mutant suggests that dephosphorylation of PDK-1 is not entirely dependent on the *H. pylori* T4SS.Fig. 4*H. pylori* type IV secretion system is not required for complete PDK-1 dephosphorylation. **a** AGS cell lysates were separated by SDS-PAGE followed by Western blotting with antibodies to phospho Ser 241 PDK-1 (upper panel), total PDK-1 protein (middle panel), or Hsp27 (lower panel). Total PDK-1 protein ran as two distinct species, one at the expected molecular weight (arrow) and at a faster migrating band (\*) that was likely proteolytically cleaved. **b** PDK-1 phosphorylation levels and total protein were quantified by normalizing to Hsp27 levels and the amount of phosphorylation or total protein expressed as a ratio of control protein, i.e. (phospho protein/Hsp27)/(total protein/Hsp27). Data are representative of at least 3 different experiments and presented as a percent of control and indicate the relative amount of phosphorylation or protein remaining in the system

Discussion {#Sec13}
==========

Disruption of cell survival signaling pathways leads to inappropriate cellular proliferation, growth, and survival, which has been implicated in the genesis and/or progression of numerous human cancers, including melanoma, breast, colon, pancreatic, prostrate, ovarian, lung, and gastric cancers \[[@CR41]--[@CR43]\]. Host signaling pathways play significant roles in the pathogenesis of *H. pylori* disease. We used the gastric adenocarcinoma cell line, AGS in the present study. The use of this cell line is invaluable and has been used as a standard model to study effects of *H. pylori* infection in gastric epithelial cells \[[@CR44]--[@CR48]\]. However, there are limitations of using this cell line given that it is a gastric cancer cell line and as such does not always represent normal cell physiology. Here, we showed that incubation of gastric epithelial cells with *H. pylori* for 24 h resulted in dephosphorylation of PDK-1. This study is the first to describe conditions that result in dephosphorylation of the PDK-1 activation loop in response to a biological stimulus. PDK-1 is pivotal in cellular functions such as proliferation, cell cycle entry, cell survival, and cytoskeletal rearrangements \[[@CR22], [@CR49]\].

Molecular events that initiate *H. pylori*-induced gastric cancer are not clearly known. Altered cell signaling mechanisms that affect cell growth and differentiation of the gastric epithelium have been suggested to be the underlying cause of gastric cancer \[[@CR50]\]. Our data suggest that an uncharacterized *H. pylori* protein is required for an intracellular mammalian phosphatase to dephosphorylate PDK-1. Evidence for this comes from experiments with heat-killed *H. pylori* that do not alter the phosphorylation state of PDK-1 (Fig. [3a](#Fig3){ref-type="fig"}) and from experiments where purified recombinant His~6~-PDK-1 was not dephosphorylated upon incubation with *H. pylori* lysates (Fig. [3b](#Fig3){ref-type="fig"}). Further, use of the Src kinase inhibitor PP2 indicated that dephosphorylation of PDK-1 was independent of Src activity (Fig. [3c](#Fig3){ref-type="fig"}). Together, these results suggest that a host factor mediates PDK-1 dephosphorylation in response to infection with *H. pylori*.

We also found that *H. pylori* dephosphorylation altered the phosphorylation status and protein stability of the PDK-1 substrate, Akt. Our observation of *H. pylori* dephosphorylation of Akt is not in disagreement with previously published studies that show *H. pylori* activate Akt \[[@CR51], [@CR52]\]. This is primarily due to the difference is the time point selected for infection. Indeed, using gastric epithelial cells Nagy et al. \[[@CR51]\] demonstrated in a very elegant study that *H. pylori* induction of Akt activation was dependent on time. The highest activation was at 2 h post infection with *H. pylori* and by 24 h, the time used in these studies, induction of Akt activation was very low \[[@CR51]\]. All these studies to date, including our present study, report that *H. pylori* infection regulates Akt activity.

Severity and progression of *H. pylori* disease has been linked to *H. pylori* virulence factors \[[@CR7], [@CR8]\]. We showed dephosphorylation of PDK-1 occurred in the presence of *H. pylori* lacking the virulence factor, *cagE*. Although there was a statistically significant difference in the amount of phosphate detected at Ser 241 in PDK-1 between cells incubated with wild type SD4 and SD4 *cag*E- mutant (Fig. [4b](#Fig4){ref-type="fig"}), a majority (\>80 %) of phosphate was removed under both conditions. This suggests that an intact T4SS played only a limited role in this process.

*H. pylori* dephosphorylation of PDK-1 and subsequent dephosphorylation of its substrates, including Akt, which regulates cell survival may therefore result in an imbalance between proliferation and apoptosis. The process of *H. pylori*-related apoptosis in involvement of gastric cancer remains controversial. While there is a consensus that increased cell proliferation favors tumorigenesis, the process that leads to the increased cell proliferation is contradictory. Some studies using animal models have reported induction of apoptosis by *H.* p*ylori* during the early stages of infection followed later by increased cell proliferation, which correlates well with what has been observed in humans infected with *H. pylori* \[[@CR53], [@CR54]\]. Overall, implications from our present study agree with the observation that there is an initial induction of apoptosis during the early infection with *H. pylori*, which leads to compensatory heightened cell proliferation associated with the development of gastric cancer. The assumption that reduced PDK-1 phosphorylation is associated with *H. pylori*-induced apoptosis could be proven during the course of *H. pylori* infection. Hence, further investigation is required to better understand how PDK-1 activity changes during *Helicobacter* disease. Nonetheless, our findings clearly demonstrate that *H. pylori* regulates PDK-1 phosphorylation at the activation loop serine, which is key for enzyme function. Although we cannot draw direct conclusions that PDK-1 dephosphorylation plays a role in *H. pylori*-induced gastric cancer, we show that incubation with *H. pylori* resulted in dephosphorylates PDK-1 protein. PDK-1 dephosphorylation is associated with induction of apoptosis \[[@CR55]--[@CR58]\]. Further, apoptosis affects the rate of new cell proliferation thereby disrupting the balance between these cellular events, a process implicated in *H. pylori*-associated carcinogenesis \[[@CR59]--[@CR62]\]. Our data provide information on cellular responses that mediate *H. pylori* infection in gastric epithelial cells.

Conclusions {#Sec14}
===========

Our study provides evidence that *H. pylori* dephosphorylates PDK-1, which alters phosphorylation and stability of the anti-apoptotic PDK-1 substrate, Akt. We show that activation loop phosphorylation of PDK-1, which plays a central role in cell survival signaling pathways, is dysregulated in response to *H. pylori* infection. This dysregulation could modify signaling responses of the host including altered rates of apoptosis and cell proliferation, which may contribute to *H. pylori*-induced gastric carcinogenesis. Imbalance between apoptosis and cell proliferation in gastric mucosal epithelia has been implicated in *H. pylori*-associated gastric carcinogenesis \[[@CR60]--[@CR62]\]. Despite testing for logical *H. pylori* and host proteins, the host protein directly involved in PDK-1 dephosphorylation remains unknown. Our present results allow us to propose that dephosphorylation of host PDK-1 may represent one of the important mechanisms by which *H. pylori* induces the development of gastric cancer.
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